nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—Danazol—Prednisone—chronic obstructive pulmonary disease	0.165	0.33	CrCrCtD
Etonogestrel—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.118	0.236	CrCrCtD
Etonogestrel—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.115	0.23	CrCrCtD
Etonogestrel—Testosterone—Prednisolone—chronic obstructive pulmonary disease	0.102	0.205	CrCrCtD
Etonogestrel—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0662	0.282	CbGbCtD
Etonogestrel—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0447	0.19	CbGbCtD
Etonogestrel—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0427	0.182	CbGbCtD
Etonogestrel—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.038	0.162	CbGbCtD
Etonogestrel—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0223	0.095	CbGbCtD
Etonogestrel—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0211	0.0897	CbGbCtD
Etonogestrel—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00171	0.0659	CbGpPWpGaD
Etonogestrel—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00151	0.0582	CbGpPWpGaD
Etonogestrel—ESR1—FOXA1 transcription factor network—SCGB1A1—chronic obstructive pulmonary disease	0.00141	0.0542	CbGpPWpGaD
Etonogestrel—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00124	0.0476	CbGpPWpGaD
Etonogestrel—ESR1—Estrogen Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.00118	0.0452	CbGpPWpGaD
Etonogestrel—ESR1—FOXA1 transcription factor network—SFTPD—chronic obstructive pulmonary disease	0.00107	0.0411	CbGpPWpGaD
Etonogestrel—ESR1—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000854	0.0328	CbGpPWpGaD
Etonogestrel—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000629	0.0242	CbGpPWpGaD
Etonogestrel—ESR1—FOXA1 transcription factor network—SERPINA1—chronic obstructive pulmonary disease	0.000577	0.0222	CbGpPWpGaD
Etonogestrel—PGR—Cellular roles of Anthrax toxin—IL1B—chronic obstructive pulmonary disease	0.000529	0.0203	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000509	0.0196	CbGpPWpGaD
Etonogestrel—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000482	0.0185	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000428	0.0165	CbGpPWpGaD
Etonogestrel—Cough—Formoterol—chronic obstructive pulmonary disease	0.000407	0.0017	CcSEcCtD
Etonogestrel—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000403	0.00169	CcSEcCtD
Etonogestrel—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000403	0.00169	CcSEcCtD
Etonogestrel—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000403	0.00169	CcSEcCtD
Etonogestrel—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000403	0.00168	CcSEcCtD
Etonogestrel—Cough—Montelukast—chronic obstructive pulmonary disease	0.000399	0.00167	CcSEcCtD
Etonogestrel—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000399	0.00167	CcSEcCtD
Etonogestrel—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000397	0.00166	CcSEcCtD
Etonogestrel—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000397	0.00166	CcSEcCtD
Etonogestrel—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.00166	CcSEcCtD
Etonogestrel—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000397	0.00166	CcSEcCtD
Etonogestrel—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000397	0.00166	CcSEcCtD
Etonogestrel—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000397	0.00166	CcSEcCtD
Etonogestrel—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000397	0.00166	CcSEcCtD
Etonogestrel—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000396	0.00166	CcSEcCtD
Etonogestrel—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000396	0.00166	CcSEcCtD
Etonogestrel—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000396	0.00166	CcSEcCtD
Etonogestrel—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000395	0.00166	CcSEcCtD
Etonogestrel—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000395	0.00166	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—TGFB2—chronic obstructive pulmonary disease	0.000395	0.0152	CbGpPWpGaD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000394	0.00165	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000394	0.00165	CcSEcCtD
Etonogestrel—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000392	0.00164	CcSEcCtD
Etonogestrel—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000392	0.00164	CcSEcCtD
Etonogestrel—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000389	0.00163	CcSEcCtD
Etonogestrel—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000389	0.00163	CcSEcCtD
Etonogestrel—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000388	0.00162	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000386	0.00162	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000386	0.00161	CcSEcCtD
Etonogestrel—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000384	0.00161	CcSEcCtD
Etonogestrel—PGR—Cellular roles of Anthrax toxin—TNF—chronic obstructive pulmonary disease	0.000384	0.0148	CbGpPWpGaD
Etonogestrel—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000381	0.00159	CcSEcCtD
Etonogestrel—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000381	0.00159	CcSEcCtD
Etonogestrel—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000381	0.00159	CcSEcCtD
Etonogestrel—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000381	0.00159	CcSEcCtD
Etonogestrel—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.00159	CcSEcCtD
Etonogestrel—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000378	0.00158	CcSEcCtD
Etonogestrel—Infection—Formoterol—chronic obstructive pulmonary disease	0.000378	0.00158	CcSEcCtD
Etonogestrel—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000375	0.00157	CcSEcCtD
Etonogestrel—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000375	0.00157	CcSEcCtD
Etonogestrel—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000375	0.00157	CcSEcCtD
Etonogestrel—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000374	0.0144	CbGpPWpGaD
Etonogestrel—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000374	0.00156	CcSEcCtD
Etonogestrel—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000373	0.00156	CcSEcCtD
Etonogestrel—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000373	0.00156	CcSEcCtD
Etonogestrel—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000373	0.00156	CcSEcCtD
Etonogestrel—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000373	0.00156	CcSEcCtD
Etonogestrel—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000373	0.00156	CcSEcCtD
Etonogestrel—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.00155	CcSEcCtD
Etonogestrel—Infection—Montelukast—chronic obstructive pulmonary disease	0.00037	0.00155	CcSEcCtD
Etonogestrel—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00037	0.00155	CcSEcCtD
Etonogestrel—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00037	0.00155	CcSEcCtD
Etonogestrel—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000369	0.00154	CcSEcCtD
Etonogestrel—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000366	0.00153	CcSEcCtD
Etonogestrel—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000365	0.00153	CcSEcCtD
Etonogestrel—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000362	0.00152	CcSEcCtD
Etonogestrel—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.0015	CcSEcCtD
Etonogestrel—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.0015	CcSEcCtD
Etonogestrel—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000357	0.00149	CcSEcCtD
Etonogestrel—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000354	0.00148	CcSEcCtD
Etonogestrel—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000353	0.00148	CcSEcCtD
Etonogestrel—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000349	0.00146	CcSEcCtD
Etonogestrel—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000348	0.00145	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000347	0.00145	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000347	0.00145	CcSEcCtD
Etonogestrel—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00144	CcSEcCtD
Etonogestrel—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00144	CcSEcCtD
Etonogestrel—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00143	CcSEcCtD
Etonogestrel—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000342	0.00143	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00034	0.00142	CcSEcCtD
Etonogestrel—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000338	0.00142	CcSEcCtD
Etonogestrel—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000338	0.00142	CcSEcCtD
Etonogestrel—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00141	CcSEcCtD
Etonogestrel—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000335	0.0014	CcSEcCtD
Etonogestrel—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.0014	CcSEcCtD
Etonogestrel—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000335	0.0014	CcSEcCtD
Etonogestrel—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000334	0.0014	CcSEcCtD
Etonogestrel—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000332	0.00139	CcSEcCtD
Etonogestrel—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000331	0.00138	CcSEcCtD
Etonogestrel—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.00033	0.00138	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000329	0.00138	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000329	0.00138	CcSEcCtD
Etonogestrel—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000328	0.00137	CcSEcCtD
Etonogestrel—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000328	0.00137	CcSEcCtD
Etonogestrel—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.00137	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000328	0.00137	CcSEcCtD
Etonogestrel—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000326	0.00136	CcSEcCtD
Etonogestrel—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000326	0.00136	CcSEcCtD
Etonogestrel—Pain—Formoterol—chronic obstructive pulmonary disease	0.000326	0.00136	CcSEcCtD
Etonogestrel—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000326	0.00136	CcSEcCtD
Etonogestrel—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00136	CcSEcCtD
Etonogestrel—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000325	0.0125	CbGpPWpGaD
Etonogestrel—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000324	0.00136	CcSEcCtD
Etonogestrel—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.00135	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000322	0.00135	CcSEcCtD
Etonogestrel—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000322	0.00135	CcSEcCtD
Etonogestrel—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00134	CcSEcCtD
Etonogestrel—Pain—Montelukast—chronic obstructive pulmonary disease	0.000319	0.00133	CcSEcCtD
Etonogestrel—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000318	0.00133	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000317	0.00133	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—HDAC2—chronic obstructive pulmonary disease	0.000317	0.0122	CbGpPWpGaD
Etonogestrel—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.00132	CcSEcCtD
Etonogestrel—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000315	0.00132	CcSEcCtD
Etonogestrel—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000315	0.00132	CcSEcCtD
Etonogestrel—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000314	0.00131	CcSEcCtD
Etonogestrel—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000314	0.00131	CcSEcCtD
Etonogestrel—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000313	0.00131	CcSEcCtD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.000313	0.012	CbGpPWpGaD
Etonogestrel—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000313	0.00131	CcSEcCtD
Etonogestrel—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000312	0.00131	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000311	0.0013	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.0013	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000311	0.012	CbGpPWpGaD
Etonogestrel—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.0013	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00031	0.0119	CbGpPWpGaD
Etonogestrel—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.0013	CcSEcCtD
Etonogestrel—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.00129	CcSEcCtD
Etonogestrel—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.00129	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000305	0.00128	CcSEcCtD
Etonogestrel—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000302	0.00127	CcSEcCtD
Etonogestrel—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000302	0.00127	CcSEcCtD
Etonogestrel—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000301	0.00126	CcSEcCtD
Etonogestrel—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000301	0.00126	CcSEcCtD
Etonogestrel—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000301	0.00126	CcSEcCtD
Etonogestrel—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000301	0.00126	CcSEcCtD
Etonogestrel—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.0003	0.00126	CcSEcCtD
Etonogestrel—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.0003	0.00126	CcSEcCtD
Etonogestrel—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000297	0.00124	CcSEcCtD
Etonogestrel—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000297	0.00124	CcSEcCtD
Etonogestrel—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000297	0.00124	CcSEcCtD
Etonogestrel—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000296	0.00124	CcSEcCtD
Etonogestrel—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.00124	CcSEcCtD
Etonogestrel—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000296	0.00124	CcSEcCtD
Etonogestrel—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000295	0.0114	CbGpPWpGaD
Etonogestrel—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000295	0.00123	CcSEcCtD
Etonogestrel—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000295	0.00123	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.00123	CcSEcCtD
Etonogestrel—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000292	0.00122	CcSEcCtD
Etonogestrel—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000291	0.00122	CcSEcCtD
Etonogestrel—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00029	0.00121	CcSEcCtD
Etonogestrel—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000289	0.00121	CcSEcCtD
Etonogestrel—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.0012	CcSEcCtD
Etonogestrel—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000284	0.00119	CcSEcCtD
Etonogestrel—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000284	0.00119	CcSEcCtD
Etonogestrel—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000283	0.0109	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000281	0.00117	CcSEcCtD
Etonogestrel—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000281	0.00117	CcSEcCtD
Etonogestrel—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00028	0.00117	CcSEcCtD
Etonogestrel—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00028	0.00117	CcSEcCtD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	0.000275	0.0106	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000275	0.00115	CcSEcCtD
Etonogestrel—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000273	0.00114	CcSEcCtD
Etonogestrel—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.00114	CcSEcCtD
Etonogestrel—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000272	0.0104	CbGpPWpGaD
Etonogestrel—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.00113	CcSEcCtD
Etonogestrel—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000269	0.00113	CcSEcCtD
Etonogestrel—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000268	0.00112	CcSEcCtD
Etonogestrel—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00111	CcSEcCtD
Etonogestrel—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00111	CcSEcCtD
Etonogestrel—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000264	0.0011	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—KL—chronic obstructive pulmonary disease	0.000263	0.0101	CbGpPWpGaD
Etonogestrel—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000261	0.01	CbGpPWpGaD
Etonogestrel—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00109	CcSEcCtD
Etonogestrel—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00109	CcSEcCtD
Etonogestrel—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00108	CcSEcCtD
Etonogestrel—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000255	0.00107	CcSEcCtD
Etonogestrel—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00106	CcSEcCtD
Etonogestrel—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000253	0.00106	CcSEcCtD
Etonogestrel—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00105	CcSEcCtD
Etonogestrel—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00105	CcSEcCtD
Etonogestrel—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000247	0.00103	CcSEcCtD
Etonogestrel—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00103	CcSEcCtD
Etonogestrel—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000242	0.00101	CcSEcCtD
Etonogestrel—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000242	0.00101	CcSEcCtD
Etonogestrel—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.001	CcSEcCtD
Etonogestrel—Rash—Formoterol—chronic obstructive pulmonary disease	0.00024	0.001	CcSEcCtD
Etonogestrel—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.001	CcSEcCtD
Etonogestrel—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00024	0.001	CcSEcCtD
Etonogestrel—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.00024	0.001	CcSEcCtD
Etonogestrel—Headache—Formoterol—chronic obstructive pulmonary disease	0.000239	0.000998	CcSEcCtD
Etonogestrel—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000239	0.000998	CcSEcCtD
Etonogestrel—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000238	0.000998	CcSEcCtD
Etonogestrel—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.000995	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000237	0.00912	CbGpPWpGaD
Etonogestrel—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000237	0.000992	CcSEcCtD
Etonogestrel—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000236	0.00907	CbGpPWpGaD
Etonogestrel—Rash—Montelukast—chronic obstructive pulmonary disease	0.000235	0.000984	CcSEcCtD
Etonogestrel—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000235	0.000983	CcSEcCtD
Etonogestrel—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.000981	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	0.000234	0.00901	CbGpPWpGaD
Etonogestrel—Depression—Prednisone—chronic obstructive pulmonary disease	0.000234	0.00098	CcSEcCtD
Etonogestrel—Headache—Montelukast—chronic obstructive pulmonary disease	0.000234	0.000978	CcSEcCtD
Etonogestrel—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000231	0.000966	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.00023	0.000964	CcSEcCtD
Etonogestrel—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.000957	CcSEcCtD
Etonogestrel—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000228	0.000954	CcSEcCtD
Etonogestrel—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.000949	CcSEcCtD
Etonogestrel—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000226	0.000948	CcSEcCtD
Etonogestrel—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000226	0.00871	CbGpPWpGaD
Etonogestrel—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.000946	CcSEcCtD
Etonogestrel—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000226	0.000946	CcSEcCtD
Etonogestrel—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.000943	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000224	0.00862	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—NOS3—chronic obstructive pulmonary disease	0.000222	0.00852	CbGpPWpGaD
Etonogestrel—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000222	0.000927	CcSEcCtD
Etonogestrel—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000219	0.000916	CcSEcCtD
Etonogestrel—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.000913	CcSEcCtD
Etonogestrel—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000215	0.00825	CbGpPWpGaD
Etonogestrel—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.000894	CcSEcCtD
Etonogestrel—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.000889	CcSEcCtD
Etonogestrel—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000212	0.000887	CcSEcCtD
Etonogestrel—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000883	CcSEcCtD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	0.000209	0.00802	CbGpPWpGaD
Etonogestrel—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000207	0.000867	CcSEcCtD
Etonogestrel—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000863	CcSEcCtD
Etonogestrel—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000863	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000206	0.00792	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	0.000199	0.00766	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—ERBB3—chronic obstructive pulmonary disease	0.000197	0.00759	CbGpPWpGaD
Etonogestrel—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000197	0.00759	CbGpPWpGaD
Etonogestrel—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000825	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000196	0.00752	CbGpPWpGaD
Etonogestrel—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000801	CcSEcCtD
Etonogestrel—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000797	CcSEcCtD
Etonogestrel—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00019	0.0073	CbGpPWpGaD
Etonogestrel—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.000781	CcSEcCtD
Etonogestrel—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000186	0.00078	CcSEcCtD
Etonogestrel—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000185	0.000775	CcSEcCtD
Etonogestrel—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000773	CcSEcCtD
Etonogestrel—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000184	0.000768	CcSEcCtD
Etonogestrel—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000184	0.000768	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—LEP—chronic obstructive pulmonary disease	0.000183	0.00702	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP9—chronic obstructive pulmonary disease	0.000178	0.00684	CbGpPWpGaD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000178	0.00683	CbGpPWpGaD
Etonogestrel—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.000738	CcSEcCtD
Etonogestrel—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000713	CcSEcCtD
Etonogestrel—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.000711	CcSEcCtD
Etonogestrel—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000702	CcSEcCtD
Etonogestrel—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000693	CcSEcCtD
Etonogestrel—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.000686	CcSEcCtD
Etonogestrel—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000666	CcSEcCtD
Etonogestrel—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000663	CcSEcCtD
Etonogestrel—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000654	CcSEcCtD
Etonogestrel—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000654	CcSEcCtD
Etonogestrel—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000652	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00065	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—KL—chronic obstructive pulmonary disease	0.000155	0.00594	CbGpPWpGaD
Etonogestrel—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000646	CcSEcCtD
Etonogestrel—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.000636	CcSEcCtD
Etonogestrel—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000627	CcSEcCtD
Etonogestrel—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000627	CcSEcCtD
Etonogestrel—Infection—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000623	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000147	0.00565	CbGpPWpGaD
Etonogestrel—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000615	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000146	0.0056	CbGpPWpGaD
Etonogestrel—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000609	CcSEcCtD
Etonogestrel—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000598	CcSEcCtD
Etonogestrel—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000139	0.00536	CbGpPWpGaD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.000137	0.00526	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—NOS3—chronic obstructive pulmonary disease	0.000137	0.00526	CbGpPWpGaD
Etonogestrel—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000571	CcSEcCtD
Etonogestrel—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000571	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000136	0.00522	CbGpPWpGaD
Etonogestrel—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000567	CcSEcCtD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	0.000135	0.00518	CbGpPWpGaD
Etonogestrel—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000563	CcSEcCtD
Etonogestrel—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000552	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000131	0.00504	CbGpPWpGaD
Etonogestrel—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000545	CcSEcCtD
Etonogestrel—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.000544	CcSEcCtD
Etonogestrel—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.000544	CcSEcCtD
Etonogestrel—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000541	CcSEcCtD
Etonogestrel—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.000541	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000128	0.00493	CbGpPWpGaD
Etonogestrel—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000536	CcSEcCtD
Etonogestrel—PGR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000126	0.00484	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000125	0.0048	CbGpPWpGaD
Etonogestrel—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000517	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000513	CcSEcCtD
Etonogestrel—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.000513	CcSEcCtD
Etonogestrel—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000498	CcSEcCtD
Etonogestrel—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000496	CcSEcCtD
Etonogestrel—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000496	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—IL1B—chronic obstructive pulmonary disease	0.000116	0.00447	CbGpPWpGaD
Etonogestrel—ESR1—LKB1 signaling events—TP53—chronic obstructive pulmonary disease	0.000116	0.00447	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	0.000116	0.00446	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—ERBB3—chronic obstructive pulmonary disease	0.000116	0.00446	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000115	0.00443	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000113	0.00434	CbGpPWpGaD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.00428	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000462	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000108	0.00414	CbGpPWpGaD
Etonogestrel—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00045	CcSEcCtD
Etonogestrel—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000444	CcSEcCtD
Etonogestrel—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000429	CcSEcCtD
Etonogestrel—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.0039	CbGpPWpGaD
Etonogestrel—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.91e-05	0.000415	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—TGFB1—chronic obstructive pulmonary disease	9.78e-05	0.00376	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—EGFR—chronic obstructive pulmonary disease	9.59e-05	0.00369	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	9.55e-05	0.00367	CbGpPWpGaD
Etonogestrel—Vomiting—Prednisone—chronic obstructive pulmonary disease	9.53e-05	0.000399	CcSEcCtD
Etonogestrel—Rash—Prednisone—chronic obstructive pulmonary disease	9.45e-05	0.000395	CcSEcCtD
Etonogestrel—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.44e-05	0.000395	CcSEcCtD
Etonogestrel—Headache—Prednisone—chronic obstructive pulmonary disease	9.39e-05	0.000393	CcSEcCtD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.14e-05	0.00351	CbGpPWpGaD
Etonogestrel—Nausea—Prednisone—chronic obstructive pulmonary disease	8.9e-05	0.000372	CcSEcCtD
Etonogestrel—Norethindrone—ALB—chronic obstructive pulmonary disease	8.62e-05	0.287	CrCbGaD
Etonogestrel—PGR—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	8.58e-05	0.0033	CbGpPWpGaD
Etonogestrel—Testosterone—CYP1A1—chronic obstructive pulmonary disease	8.52e-05	0.283	CrCbGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	8.25e-05	0.00317	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	8.22e-05	0.00316	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.19e-05	0.00315	CbGpPWpGaD
Etonogestrel—Methyltestosterone—ALB—chronic obstructive pulmonary disease	8.18e-05	0.272	CrCbGaD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.09e-05	0.00311	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	7.96e-05	0.00306	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	7.87e-05	0.00302	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	7.39e-05	0.00284	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	7.2e-05	0.00277	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.64e-05	0.00255	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	6.6e-05	0.00254	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.23e-05	0.00239	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—CTGF—chronic obstructive pulmonary disease	6.06e-05	0.00233	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.84e-05	0.00225	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.78e-05	0.00222	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	5.74e-05	0.00221	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	5.65e-05	0.00217	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.63e-05	0.00216	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5.06e-05	0.00195	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	5.04e-05	0.00194	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.02e-05	0.00193	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.86e-05	0.00187	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.82e-05	0.00185	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.79e-05	0.00184	CbGpPWpGaD
Etonogestrel—Testosterone—ALB—chronic obstructive pulmonary disease	4.75e-05	0.158	CrCbGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.66e-05	0.00179	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.28e-05	0.00165	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.25e-05	0.00163	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.2e-05	0.00161	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.05e-05	0.00156	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4e-05	0.00154	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.99e-05	0.00154	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	3.87e-05	0.00149	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.72e-05	0.00143	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.67e-05	0.00141	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.67e-05	0.00141	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.66e-05	0.00141	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—CTGF—chronic obstructive pulmonary disease	3.56e-05	0.00137	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.53e-05	0.00136	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.52e-05	0.00135	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.48e-05	0.00134	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.41e-05	0.00131	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	3.37e-05	0.00129	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	3.31e-05	0.00127	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.15e-05	0.00121	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.95e-05	0.00113	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.84e-05	0.00109	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.81e-05	0.00108	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.76e-05	0.00106	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.56e-05	0.000984	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.46e-05	0.000947	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.29e-05	0.00088	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.15e-05	0.000828	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2e-05	0.00077	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.88e-05	0.000723	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.85e-05	0.000711	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.83e-05	0.000703	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.8e-05	0.000691	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.71e-05	0.000659	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.7e-05	0.000654	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.65e-05	0.000635	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.62e-05	0.000623	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.52e-05	0.000585	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.5e-05	0.000577	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.45e-05	0.000556	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.38e-05	0.000529	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.34e-05	0.000516	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.24e-05	0.000475	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.13e-05	0.000436	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.11e-05	0.000427	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.05e-05	0.000405	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.01e-05	0.000387	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.99e-06	0.000384	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	9.88e-06	0.00038	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.34e-06	0.000359	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	9.01e-06	0.000347	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.93e-06	0.000343	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.54e-06	0.000329	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.31e-06	0.000319	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.08e-06	0.00031	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.25e-06	0.000279	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.93e-06	0.000266	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.83e-06	0.000263	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.66e-06	0.000256	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.53e-06	0.000251	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.37e-06	0.000245	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.03e-06	0.000232	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.48e-06	0.000211	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.02e-06	0.000193	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.1e-06	0.000158	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.92e-06	0.000151	CbGpPWpGaD
